Demand for bio-based brake fluid formulation components will increase through 2036, with passenger cars at 58.2% of end use share and service fill at 52.4% of vehicle channel share in 2026. The market was valued at USD 183.3 million in 2025 and is expected to reach USD 337.4 million by 2036.